Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Bruno Lina and Andrés Pizzorno.
Bruno Lina
Connection Strength
0.797
Andrés Pizzorno
  1. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia. Cell Rep Med. 2020 07 21; 1(4):100059.
    View in: PubMed
    Score: 0.223
  2. In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antiviral Res. 2020 09; 181:104878.
    View in: PubMed
    Score: 0.223
  3. Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 Oct 04; 218(10).
    View in: PubMed
    Score: 0.060
  4. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 10 04; 218(10).
    View in: PubMed
    Score: 0.060
  5. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus. Molecules. 2021 Apr 29; 26(9).
    View in: PubMed
    Score: 0.059
  6. SARS-CoV-2 viral dynamics in non-human primates. PLoS Comput Biol. 2021 03; 17(3):e1008785.
    View in: PubMed
    Score: 0.058
  7. Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model. Microorganisms. 2020 Dec 11; 8(12).
    View in: PubMed
    Score: 0.057
  8. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020 09; 585(7826):584-587.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.